During the past decade, First Hospital of Shanxi Medical University conducted 128 clinical trials. In the 10-year time frame, 128 clinical trials started and 13 clinical trials were completed, i.e. on average, 10.2% percent of trials that started reached the finish line to date. In the past 5 years, 85 clinical trials started and 10 clinical trials were completed. i.e. 11.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "First Hospital of Shanxi Medical University" #1 sponsor was "Beijing Friendship Hospital" with 6 trials, followed by "Reistone Biopharma Company Limited" with 6 trials sponsored, "Beijing Tiantan Hospital" with 5 trials sponsored, "Second Hospital of Shanxi Medical University" with 5 trials sponsored and "Beijing Chao Yang Hospital" with 5 trials sponsored. Other sponsors include 120 different institutions and companies that sponsored additional 93 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "First Hospital of Shanxi Medical University" #1 collaborator was "The First Affiliated Hospital of Shanxi Medical University" with 13 trials as a collaborator, "Peking University First Hospital" with 9 trials as a collaborator, "Second Hospital of Shanxi Medical University" with 9 trials as a collaborator, "Peking Union Medical College Hospital" with 7 trials as a collaborator and "Tang-Du Hospital" with 7 trials as a collaborator. Other collaborators include 491 different institutions and companies that were collaborators in the rest 280 trials.

According to Clinical.Site data, the most researched conditions in "First Hospital of Shanxi Medical University" are "Acute Ischemic Stroke" (5 trials), "Hypertension" (4 trials), "Pulmonary Embolism" (4 trials), "Type 2 Diabetes" (4 trials) and "Alzheimer Disease" (3 trials). Many other conditions were trialed in "First Hospital of Shanxi Medical University" in a lesser frequency.

Most popular intervention types in "First Hospital of Shanxi Medical University" are "Drug" (109 trials), "Biological" (12 trials), "Other" (11 trials), "Device" (7 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "SHR0302" (4 trials), "Placebos" (3 trials), "placebo" (3 trials) and "Amlodipine besylate tablets" (2 trials). Other intervention names were less common.

The vast majority of trials in "First Hospital of Shanxi Medical University" are 138 trials for "All" genders, 8 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are 62 active trials in "First Hospital of Shanxi Medical University". 7 are not yet recruiting, 41 are recruiting, 13 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 55 completed trials in First Hospital of Shanxi Medical University, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in First Hospital of Shanxi Medical University, 10 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 27 trials, and there were also 16 trials that are defined as “Not Applicable".